A comparison of body lotion containing Dead Sea minerals to two body lotions without Dead Sea minerals in the treatment of skin problems in hemodialysis patients

Phase 3

Completed

• Conditions: uremic pruritus; Skin - Dermatological conditions

• Registration Number: ACTRN12610000741088
• Lead Sponsor: Ahava Dead Sea Laboratories and Dead Sea Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Hemodialysis (HD) patients aged 40-80 years inclusive were eligible for study participation if they received HD treatment three times each week for not less than three months, and if they were willing to refrain from any antipruritic treatment, oral or topical, for a period of not less than two weeks prior to study initiation. Patients of both genders, without regard to comorbidities or prescribed medications, were eligible.

Exclusion Criteria

Patient unwillingness to participate for any reason; known sensitivity to any of the ingredients in the active or placebo treatments.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-rated severity (rated on a 5-point Likert scale) of cutaneous manifestations of uremic pruritus (itching, peeling, tightness, dryness).[Two weeks from initiation of treatment exposure]

Secondary Outcome Measures

Name	Time	Method
Within group self-rated change from baseline severity (rated on a 5-point Likert scale) of cutaneous manifestations of uremic pruritus (itching, peeling, tightness, dryness)[Two weeks from initiation of treatment exposure]